These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19233606)

  • 41. Subclinical neurological involvement does not develop if Wilson's disease is treated early.
    Dubbioso R; Ranucci G; Esposito M; Di Dato F; Topa A; Quarantelli M; Matarazzo M; Santoro L; Manganelli F; Iorio R
    Parkinsonism Relat Disord; 2016 Mar; 24():15-9. PubMed ID: 26851839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the human Atox 1 homologue in Wilson patients.
    Simon I; Schaefer M; Reichert J; Stremmel W
    World J Gastroenterol; 2008 Apr; 14(15):2383-7. PubMed ID: 18416466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Wilson disease].
    Shimizu N
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):170-2. PubMed ID: 9645034
    [No Abstract]   [Full Text] [Related]  

  • 44. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coincidence of 2 severe chronic diseases: presymptomatic diagnosis of Wilson disease in a boy with severe haemophilia A.
    Hainmann I; Woltering T; Greiner P; Nakamura L; Podskarbi T; Oldenburg J; Zieger B
    Klin Padiatr; 2013 May; 225(3):174-5. PubMed ID: 23709134
    [No Abstract]   [Full Text] [Related]  

  • 46. Secondary glaucoma with copper deposition in trabecular meshwork in Wilson disease.
    Li X; Ye T; Li Y; Zhang X
    Clin Exp Ophthalmol; 2014 Mar; 42(2):204-5. PubMed ID: 23601675
    [No Abstract]   [Full Text] [Related]  

  • 47. Early and severe liver disease associated with homozygosity for an exon 7 mutation, G691R, in Wilson's disease.
    Barada K; Nemer G; ElHajj II; Touma J; Cortas N; Boustany RM; Usta J
    Clin Genet; 2007 Sep; 72(3):264-7. PubMed ID: 17718866
    [No Abstract]   [Full Text] [Related]  

  • 48. The story of penicillamine: a difficult birth.
    Walshe JM
    Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074
    [No Abstract]   [Full Text] [Related]  

  • 49. Early Onset of Wilson Disease: Diagnostic Challenges.
    Wiernicka A; Dądalski M; Jańczyk W; Kamińska D; Naorniakowska M; Hüsing-Kabar A; Schmidt H; Socha P
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):555-560. PubMed ID: 28753182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation.
    Kim TJ; Kim IO; Kim WS; Cheon JE; Moon SG; Kwon JW; Seo JK; Yeon KM
    AJNR Am J Neuroradiol; 2006; 27(6):1373-8. PubMed ID: 16775300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear magnetic resonance brain study in a case of Wilson disease.
    Longhi R; Riva E; Rottoli A; Valsasina R; Pinelli P; Giovannini M
    J Inherit Metab Dis; 1989; 12 Suppl 2():386-8. PubMed ID: 2512451
    [No Abstract]   [Full Text] [Related]  

  • 52. MRI of the brain in Wilson disease: T2 signal loss under therapy.
    Engelbrecht V; Schlaug G; Hefter H; Kahn T; Mödder U
    J Comput Assist Tomogr; 1995; 19(4):635-8. PubMed ID: 7622700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Wilson disease].
    Woimant F; Chaine P; Favrole P; Mikol J; Chappuis P
    Rev Neurol (Paris); 2006 Jun; 162(6-7):773-81. PubMed ID: 16840991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Advances in the treatment of Wilson Disease].
    Xiao QQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):79-82. PubMed ID: 33541028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wilson disease and its current problems.
    Harada M
    Intern Med; 2010; 49(9):807-8. PubMed ID: 20453398
    [No Abstract]   [Full Text] [Related]  

  • 56. [A favorable outcome of pregnancy with Wilson-Konovalov disease (a clinical case)].
    Padrul MM; Olina AA; Sadykova GK
    Wiad Lek; 2018; 71(5):1109-1113. PubMed ID: 30176651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy.
    Brewer GJ; Johnson V; Dick RD; Kluin KJ; Fink JK; Brunberg JA
    Arch Neurol; 1996 Oct; 53(10):1017-25. PubMed ID: 8859064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serial changes of cranial computerized tomographic findings in Wilson disease during D-penicillamine therapy.
    Mizutani N; Maehara M; Negoro T; Watanabe K
    Brain Dev; 1983; 5(1):48-52. PubMed ID: 6846733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The copper metallome in eukaryotic cells.
    Vest KE; Hashemi HF; Cobine PA
    Met Ions Life Sci; 2013; 12():451-78. PubMed ID: 23595680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease.
    Wiggelinkhuizen M; Tilanus ME; Bollen CW; Houwen RH
    Aliment Pharmacol Ther; 2009 May; 29(9):947-58. PubMed ID: 19210288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.